Review of the 2nd day of the II Scientific and Practical Conference in a hybrid format “Achievements, problems and prospects in hematology”. Treatment and diagnosis of patients wit... door V. A. Shuvaev

Volledige tekst

How we treat polycythemia vera door V. A. Shuvaev, I. S. Martynkevich

Volledige tekst

All we know about polycythemia vera: literature review and own experience door K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Volledige tekst

Dasatinib: ten years of clinical practice worldwide door K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Volledige tekst

Primary myelofibrosis: own experience and news from diagnostic and treatment door K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Volledige tekst

Primary myelofibrosis: own experience and news from diagnostic and treatment door K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Volledige tekst

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission door V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Volledige tekst

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission door V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Volledige tekst

Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults door E. A. Pyadushkina, M. Yu. Frolov, V. A. Shuvaev, V. A. Rogov

Volledige tekst

Clinical Case of Posterior Reversible Encephalopathy Syndrome in a Female Patient Undergoing Surgery for Rectal Cancer door M. M. Geraskinа, A. B. Galitsynа, V. A. Shuvaev, S. S. Gosteva

Volledige tekst

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma door S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Volledige tekst

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma door S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Volledige tekst

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis door M. S. Fominykh, V. A. Shuvaev, I. S. Martynkevich, L. B. Polushkina, V. Yu. Udal’eva, K. M. Abdulkadyrov

Volledige tekst

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients door V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Volledige tekst

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients door V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Volledige tekst

Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia door D. V. Kustova, E. V. Motyko, A. N. Kirienko, T. N. Gert, I. V. Leppyanen, M. P. Bakay, E. V. Efremova, E. V. Morozova, E. G. Lomaia, V. A. Shuvaev, S. V. Sidorkevich, I. S. Martynkevich

Volledige tekst

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA door A. A. Zhernyakova, I. S. Martynkevich, V. A. Shuvaev, L. B. Polushkina, M. S. Fominykh, V. Yu. Udal’eva, I. I. Zotova, D. I. Shiсhbabaeva, S. V. Voloshin, S. S. Бессмельцев, A. V. Chechetkin, K. M. Abdulkadyrov

Volledige tekst

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients door S. V. Voloshin, A. D. Garifullin, A. A. Kuzyaeva, N. N. Sinitsina, N. N. Alekseeva, A. V. Schmidt, S. Y. Linnikov, V. A. Shuvaev, A. Y. Kuvshinov, N. A. Potikhonova, A. V. Seltser, V. A. Balashova, Z. V. Chubukina, A. N. Bogdanov, S. V. Sidorkevich

Volledige tekst

Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy door A G Turkina, E Yu Chelysheva, V A Shuvaev, G A Gusarova, A V Bykova, O A Shukhov, A N Petrova, M V Vakhrusheva, S R Goryacheva, L Yu Kolosova, P S Krasikova, M S Fominykh, I S Martynkevich, A O Abdullaev, A B Sudarikov, V G Savchenko

Volledige tekst